Johnson & Johnson - Significant Ownership

Signature - Title
/s/ Marc Larkins - Mark Larkins/Secretary
Location
New Brunswick, NJ
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Johnson & Johnson.

Significant Ownership of Johnson & Johnson

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RAPP Rapport Therapeutics, Inc. Common Stock, $0.001 par value 4.9% $53M 1.78M JOHNSON & JOHNSON Sep 30, 2025

Schedules 13D/G Reported by Johnson & Johnson:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.